SCHEMBL29761613

SCHEMBL29761613

CCOC(=O)c1c(Br)n[nH]c1C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 1/20 0.71
▸ MAPT P10636 4/20 0.54
▸ KDM4E B2RXH2 2/20 0.54
▸ POLB P06746 2/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ SMN1; SMN2 Q16637 4/20 0.50
▸ HPGD P15428 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.44
▸ GAA P10253 3/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ MAPK10 P53779 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ AURKA O14965 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA7 P43166 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1614317 0.86 PDE4D (0.56) PDE4DMAPTKDM4EPOLBKMT2A
SCHEMBL353564 0.83 PDE4D (1.00) PDE4DMAPTKDM4EPOLBKMT2A
SCHEMBL23013132 0.83 PDE4D (0.53) PDE4DMAPTKDM4EPOLBKMT2A
SCHEMBL3262021 0.81 PDE4D (0.51) PDE4DMAPTKDM4EPOLBKMT2A
SCHEMBL23122563 0.81 PDE4D (0.51) PDE4DMAPTKDM4EPOLBKMT2A
SCHEMBL7513038 0.80 PDE4D (0.73) PDE4DMAPTKDM4EPOLBKMT2A
SCHEMBL31367819 0.80 PDE4D (0.73) PDE4DMAPTKDM4EPOLBKMT2A
SCHEMBL20583553 0.79 PDE4D (0.49) PDE4DMAPTKDM4EPOLBKMT2A
SCHEMBL23001765 0.79 PDE4D (0.71) PDE4DMAPTKDM4EPOLBKMT2A
SCHEMBL600955 0.79 PDE4D (0.71) PDE4DMAPTKDM4EPOLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4288435-A1 TRICYCLIC-AMIDO-BICYCLIC PRMT5 INHIBITORS Amgen Inc. (US) 2023-12-13 — — EP disclosed
EP-4263545-A1 PRMTS INHIBITORS Amgen Inc. (US) 2023-10-25 — — EP disclosed
WO-2022169948-A1 TRICYCLIC-AMIDO-BICYCLIC PRMT5 INHIBITORS AMGEN INC. (US) 2022-08-11 — — WO disclosed
WO-2022132914-A1 PRMTS INHIBITORS AMGEN INC. (US) 2022-06-23 — — WO disclosed
Send feedback